Blog

Healthcare innovation

Integrum expands and relocates to GoCo Health…

Integrum expands and relocates to GoCo Health…

<![CDATA[ function CopyToClipboard(text, type) { if (!navigator.clipboard) { return; } navigator.clipboard.writeText(text).then(function() { console.log('Copying to clipboard was successful!'); }, function(err) { console.error('Could not copy text: ', err); }); alert("COPY/PASTE: This link is designed for copying the relevant security "+type+". You can now paste it to your liking."); return false; } function showDiscover_pdf() { var myDivPubBg = document.getElementById('dPubBg'); var myDivPubInter = document.getElementById('dPubInter'); var myDivPubContent = document.getElementById('dPubBgC'); var myDivPubContent2 = document.getElementById('dPubBgC2_pdf'); var myTabPP = document.getElementById('tabpopup'); var AvH = window.innerHeight – 650; if (window.innerHeight<650) AvH=window.innerHeight; if (AvH<0) AvH=0; myDivPubContent.innerHTML = myDivPubContent2.innerHTML; document.getElementById('divpopup').innerHTML = "”; myDivPubContent.style.marginLeft = ‘-420px’; myTabPP.width = “700px”; myDivPubBg.style.width = ‘100%’; myDivPubBg.style.height = ‘100%’; myDivPubBg.style.backgroundColor = ‘#6b6b6b’; myDivPubBg.style.display=’block’; myDivPubInter.style.top = (AvH/2)+’px’; myDivPubInter.style.display=’block’; document.getElementById(“divpopup”).style.display = “block”; } function closeDiscover_pdf() { var myDivPubBg = document.getElementById(‘dPubBg’); var myDivPubInter = document.getElementById(‘dPubInter’); var myDivPubContent = document.getElementById(‘dPubBgC’); var myDivPubContent2 = document.getElementById(‘dPubBgC2_pdf’); myDivPubContent.innerHTML = myDivPubContent2.innerHTML; myDivPubContent.style.marginLeft = ‘-400px’; myDivPubBg.style.width = ‘0%’; myDivPubBg.style.height = ‘0%’; myDivPubBg.style.display=’none’; myDivPubInter.style.display=’none’; myDivPubContent2.style.display = “none”; document.getElementById(‘divpopup’).style.display = “none”; document.getElementById(‘divpopup’).innerHTML = “”; } ]]> fermer

Delayed Nasdaq Stockholm  –  11:29 2022-06-13 am EDT
38.65 SEK  -5.62%

{SS_ISE_LOADED.push(event);}) ]]>

‘); $(‘#TABLEARTICLE’).find(‘tr:gt(10)’).hide(); $(‘#TABLEARTICLE’).find(‘tr:nth-child(11)’).click(function() { $(this).remove(); $(‘#TABLEARTICLE’).find(‘tr’).show(); }); } } }); <![CDATA[ $(function() { var sHTMLGraphCours = "“; if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width0) { if(window.screen.width

<![CDATA[ var sHTMLAutopromo = "
The best opportunities. All the markets. Each month. In one click. Discover &nbsp “; $(function(){ $.each($(“.autopromo”),function(index,elmnt){ $(elmnt).css(“display”,””); $(elmnt).html(sHTMLAutopromo); }); if(window.screen.width

Mölndal, Sweden, June 13, 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company will move its headquarter to GoCo Health Innovation City in Mölndal, Gothenburg. The relocation which will take place in the spring of 2023 is a logical next step for the company, as it has outgrown its current premises.

Integrum is experiencing strong commercial development and expansion. As a result, the company signed a contract today to relocate to new premises in the GoCo House, in the center of GoCo Health Innovation City, a new life science district in Gothenburg. The new city area is set to cover over 200 000 square meters of newly developed offices and facilities, with the aim of promoting knowledge exchange, business collaboration, and world-class innovation in life science and health care. Other innovative companies such as Siemens Healthineers and Xvivo Perfusion have already signed up as tenants in the new facility and global actors like AstraZeneca and Mölnlycke HealthCare are in the close neighborhood.

“We look forward to joining the innovative and collaborative environment in GoCo Health Innovation City. Besides providing us with the space we need for our ongoing expansion, we believe the relocation will make us an even more attractive employer to the best minds in the field,” comments Rickard Brånemark, CEO of Integrum.

“We are thrilled to have companies that are at the forefront of the respective industry moving into GoCo House. It is together that we can create innovation and change the opportunities for tomorrow. With Integrum’s expertise and mission, the company will bring a lot of value in itself. Integrum will also be an inspiring business both in terms of collaborations and future world-class innovation”, comments Jonas Obert, business developer at GoCo Health Innovation City.

GoCo is being built in three phases. The building that Integrum will be located in is planned to be completed at the end of 2022, and Integrum will move in during the spring of 2023.

For more information please contact:

Rickard Brånemark, CEO. Phone: +46 70 846 10 61, E-mail: rickard.branemark@integrum.se

Dennis Baecklund, CFO. Phone: +46 72 556 68 69, E-mail: dennis.baecklund@integrum.se

Certified Adviser

Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.

Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a US subsidiary in San Francisco, CA. Since 1990, osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations enjoy a dramatically improved quality of life. Thorough surgical experience gained over more than three decades, from more than 500 surgeries, in 14 countries, has led to the development of Integrum’s system for bone-anchored prostheses – a vastly superior alternative to the traditionally used socket prosthesis

https://news.cision.com/integrum-ab/r/integrum-expands-and-relocates-to-goco-health-innovation-city,c3584071

https://mb.cision.com/Main/17531/3584071/1591860.pdf

(c) 2022 Cision. All rights reserved., source Press Releases – English

<![CDATA[ $('#TABLEARTICLE').on('mouseover.tabBodyLV17','.LChartI', function(event) { var this_ = this; var width = 300; var codezb = $(this_).parent().find("a").attr("codezb");/*$("div.iconeSuppr", $(this_).closest("tr")).attr("codezb");*/ var at = $(this_).parent().find("a").attr("at"); var elemRect = this.getBoundingClientRect(),/*+ window.scrollY,*/ siteRect = $("#myCENTER")[0].getBoundingClientRect(), x_offset = elemRect.left – siteRect.left + 35; var img = "“; var LChart = $(‘#LChart’); LChart.detach() .insertAfter(this) .css(“left”, x_offset) .html(img).css(“display”, “block”); $(this_).on(‘mouseout’, function() { $(‘#LChart’).css(“display”, “none”); $(this_).off( “mouseout”); }); }); ]]> 10) { $(‘#TABLEARTICLE’).find(‘tr:nth-child(10)’).after(‘

More Results]]>

All news about INTEGRUM AB (PUBL)

Sales 2022 70,7 M 7,06 M 7,06 M
Net income 2022 16,8 M 1,68 M 1,68 M
Net cash 2022 90,0 M 8,98 M 8,98 M
P/E ratio 2022
Yield 2022
Capitalization 739 M 73,7 M 73,7 M
EV / Sales 20229,17x
EV / Sales 20236,72x
Nbr of Employees29
Free-Float49,6%

Chart INTEGRUM AB (PUBL)
Duration : Auto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax. Period : DayWeek

Integrum AB (publ) Technical Analysis Chart | MarketScreener

Income Statement Evolution

Please enable JavaScript in your browser’s settings to use dynamic charts.

Sell

Buy

Mean consensusBUY
Number of Analysts0
Last Close Price40,95 SEK
Average target price100,00 SEK
Spread / Average Target144%

Please enable JavaScript in your browser’s settings to use dynamic charts.

Source